BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26755874)

  • 1. Current status and perspectives of immune-based therapies for hepatocellular carcinoma.
    Aerts M; Benteyn D; Van Vlierberghe H; Thielemans K; Reynaert H
    World J Gastroenterol; 2016 Jan; 22(1):253-61. PubMed ID: 26755874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic approaches for hepatocellular carcinoma.
    Longo V; Gnoni A; Casadei Gardini A; Pisconti S; Licchetta A; Scartozzi M; Memeo R; Palmieri VO; Aprile G; Santini D; Nardulli P; Silvestris N; Brunetti O
    Oncotarget; 2017 May; 8(20):33897-33910. PubMed ID: 28420805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
    Repáraz D; Aparicio B; Llopiz D; Hervás-Stubbs S; Sarobe P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for hepatocellular carcinoma.
    Li S; Yang F; Ren X
    Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.
    Wirth TC
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):101-10. PubMed ID: 24410473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.
    Liu Z; Liu X; Liang J; Liu Y; Hou X; Zhang M; Li Y; Jiang X
    Front Immunol; 2021; 12():765101. PubMed ID: 34675942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of immunotherapy for hepatocellular carcinoma.
    Breous E; Thimme R
    J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for successful vaccination against hepatocellular carcinoma.
    Rinaldi M; Iurescia S; Fioretti D; Ponzetto A; Carloni G
    Int J Immunopathol Pharmacol; 2009; 22(2):269-77. PubMed ID: 19505380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-based therapies for hepatocellular carcinoma.
    Pinato DJ; Guerra N; Fessas P; Murphy R; Mineo T; Mauri FA; Mukherjee SK; Thursz M; Wong CN; Sharma R; Rimassa L
    Oncogene; 2020 Apr; 39(18):3620-3637. PubMed ID: 32157213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges.
    Wang L; Wang FS
    Hepatol Int; 2019 Sep; 13(5):521-533. PubMed ID: 31352593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for hepatocellular carcinoma: Current and future.
    Johnston MP; Khakoo SI
    World J Gastroenterol; 2019 Jun; 25(24):2977-2989. PubMed ID: 31293335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.
    Mukaida N; Nakamoto Y
    World J Gastroenterol; 2018 May; 24(17):1839-1858. PubMed ID: 29740200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
    Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives.
    Shen KY; Zhu Y; Xie SZ; Qin LX
    J Hematol Oncol; 2024 Apr; 17(1):25. PubMed ID: 38679698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the immune system in the control of hepatocellular carcinoma.
    O'Beirne JP; Harrison PM
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1257-60. PubMed ID: 15618828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.
    Jiang Y; Han QJ; Zhang J
    World J Gastroenterol; 2019 Jul; 25(25):3151-3167. PubMed ID: 31333308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
    Harding JJ; El Dika I; Abou-Alfa GK
    Cancer; 2016 Feb; 122(3):367-77. PubMed ID: 26540029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in immunotherapy for hepatocellular cancer.
    Butterfield LH
    Swiss Med Wkly; 2007 Feb; 137(5-6):83-90. PubMed ID: 17370144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC.
    El Ansary M; Mogawer S; Elhamid SA; Alwakil S; Aboelkasem F; Sabaawy HE; Abdelhalim O
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):39-48. PubMed ID: 22886490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.